Dr. Mohsen I. Mabudian, MD

Dr. Mabudian practices at Arrowhead Regional Medical Center in Colton, California.

Dr. Mabudian's NPI, 1629022819, was assigned on May 20, 2006. Dr. Mabudian graduated from St. George's University School of Medicine in 1997. Dr. Mabudian holds California license C51804.

Dr. Mabudian's primary practice is Arrowhead Regional Medical Center, at 400 N Pepper Ave, Colton, CA 92324 in San Bernardino County. The practice phone is (909) 580-1000.

Dr. Mabudian's primary practice is Arrowhead Regional Medical Center in Colton, California. The medical group on file is OSO Home Care, Inc. Dmand AI also links Dr. Mabudian to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mabudian practices. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Mabudian's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Mabudian is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Mabudian's licenses on file in 3 states: California, New Jersey and Louisiana.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Mabudian treats.

CMS data shows 117,364 Medicare services from Dr. Mabudian across 19 procedure codes in 2024, for 281 Medicare patients. Medicare paid $2,496,669 for them. Every service was in an office.

CMS counts 281 Medicare patients who saw Dr. Mabudian in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mabudian's median patient age at 40, with 64% women.

In 2024, Dr. Mabudian wrote 428 Medicare Part D claims for 63 patients. 68% of them were for generic drugs. CMS names the drug for 321 of them, across 16 drugs with 11 or more claims each, at $197,275 in total drug cost. In 2023, CMS named 165 claims across 10 drugs.

CMS lists Dr. Mabudian as offering telehealth.

Dmand AI links 3 papers to Dr. Mabudian, published from 2014 to 2024. Dr. Mabudian's most frequent co-authors are Enrique Garcia, DPT, Enrique E. Garcia, MD and Sudhir Gupta, MD.

Dmand AI links Dr. Mabudian to 1 clinical trial. Conditions studied include Primary Immunodeficiency Diseases and Immunologic Deficiency Syndromes. Open Payments lists research payments to Dr. Mabudian that name 1 trial.

CMS Open Payments shows 1,138 general payments to Dr. Mabudian from 41 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. Shire North American Group Inc paid the most, $50,942. It also lists 3 research payments totaling $3,000 in 2021, naming 1 clinical trial.

Dr. Mabudian graduated from St. George's University School of Medicine in 1997. Dr. Mabudian is a member of AAAAI.

Dr. Mabudian is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.